Literature DB >> 23888553

Expression of Toll like receptors 3 & 7 in peripheral blood from patients with chronic hepatitis C virus infection and their correlation with interferon-alpha.

Kawthar I Mohammed1, Lamiaa A Adel, Fatma A Ali-Eldin, Sahar Eladawy.   

Abstract

Toll-like receptor 3 (TLR3) and Toll-like receptor 7 (TLR7) are pathogen- recognition receptors that are expressed on innate immune cells. They recognize viral RNA which induces their activation with subsequent increase in IFN-alpha transcription. It has been postulated that HCV may cause down regulation of these receptors as one of immune evading mechanisms that participate in viral persistence. The aim of this work is to investigate the expression of Toll-like receptors 3 (TLR3) and 7 (TLR7) in peripheral blood from patients with chronic hepatitis C infection and correlate their expression to the peripheral blood expression of interferon-alpha (IFN-alpha), viral load and histopathology of the liver. IFN-alpha, TLR3 and TLR7 expression in peripheral blood from patients with chronic hepatitis C infection (n = 30) and from healthy controls (n = 20) were measured by real time polymerase chain reaction. Viral load and Liver biopsy were done for all patients. The results showed lower expression of TLR3 and TLR7 in patients than controls, and levels of expression correlated positively with IFN-alpha expression. No correlation was found between TLR3 and TLR7 and viral load or histopathological staging and grading of the liver tissue. In conclusion, HCV may induce down regulation of TLRs (TLR3 and TLR7) expression on innate immune cells with subsequent decrease in INF-alpha production suggesting that new therapies that aim to increase the expression level of TLRs may help in treatment of HCV infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23888553

Source DB:  PubMed          Journal:  Egypt J Immunol


  7 in total

Review 1.  Toll-like Receptor Response to Hepatitis C Virus Infection: A Recent Overview.

Authors:  Mohammad Enamul Hoque Kayesh; Michinori Kohara; Kyoko Tsukiyama-Kohara
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

2.  Modulation of TLR 3, 7 and 8 expressions in HCV genotype 3 infected individuals: potential correlations of pathogenesis and spontaneous clearance.

Authors:  Rushna Firdaus; Aritra Biswas; Kallol Saha; Anirban Mukherjee; Falguni Pal; Sujit Chaudhuri; Alok Chandra; Asokananda Konar; Provash Chandra Sadhukhan
Journal:  Biomed Res Int       Date:  2014-07-13       Impact factor: 3.411

3.  Association of Toll-Like Receptor 3 Single-Nucleotide Polymorphisms and Hepatitis C Virus Infection.

Authors:  Mashael R Al-Anazi; Sabine Matou-Nasri; Ayman A Abdo; Faisal M Sanai; Saad Alkahtani; Saud Alarifi; Abdullah A Alkahtane; Hamad Al-Yahya; Daoud Ali; Mohammed S Alessia; Bushra Alshahrani; Mohammed N Al-Ahdal; Ahmed A Al-Qahtani
Journal:  J Immunol Res       Date:  2017-01-03       Impact factor: 4.818

4.  Distinct Toll-like Receptor 3 and 7 Expression in Peripheral Blood Mononuclear Cells From Patients with Chronic Hepatitis C Infection.

Authors:  Mahsa Motavaf; Fatemeh Noorbakhsh; Seyed Moayed Alavian; Zohreh Sharifi
Journal:  Hepat Mon       Date:  2014-04-07       Impact factor: 0.660

5.  Transcriptional Dysregulation of Upstream Signaling of IFN Pathway in Chronic HCV Type 4 Induced Liver Fibrosis.

Authors:  Marwa K Ibrahim; Ghada Maher Salum; Noha G Bader El Din; Reham M Dawood; Ahmed Barakat; Ahmed Khairy; Mostafa K El Awady
Journal:  PLoS One       Date:  2016-05-02       Impact factor: 3.240

Review 6.  Toll-Like Receptor 3 is Associated With the Risk of HCV Infection and HBV-Related Diseases.

Authors:  Pei-Liang Geng; Li-Xue Song; Huaijie An; Jing-Yu Huang; Sheng Li; Xian-Tao Zeng
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

7.  Intrahepatic TLR3 and IFNL3 Expressions Are Associated with Stages of Fibrosis in Chronic Hepatitis C.

Authors:  Keyla Santos Guedes de Sá; Ednelza da Silva Graça Amoras; Simone Regina Souza da Silva Conde; Maria Alice Freitas Queiroz; Izaura Maria Vieira Cayres-Vallinoto; Ricardo Ishak; Antonio Carlos Rosário Vallinoto
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.